Lemaitre Vascular (LMAT) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
LeMaitre Q1 2015 Record Sales $18.9mm (+13%), Op. Inc. $2.3mm
April 28, 2015 4:06 PM EDTBURLINGTON, Mass., April 28, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, today reported Q1 2015 results, announced a $0.04/share dividend and provided guidance.
Q1 2015 results included:
Record sales of $18.9mm, +13% vs. Q1 2014 Operating income of $2.3mm vs. an operating loss of $0.2mm Operating margin of 12% Net income of $1.4mm vs. a net loss of $0.2mm Earnings of $0.08 per diluted share vs. ($0.01) EBITDA of $3.2mm vs. $0.6mmQ1 2015 sales of $18.9mm increased 13% (+14% organic) vs. Q1 2014. International sales increased 15%, while The Americas... More
LeMaitre Q1 2015 Record Sales $18.9mm (+13%), Op. Inc. $2.3mm
April 28, 2015 4:05 PM EDTBURLINGTON, Mass., April 28, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, today reported Q1 2015 results, announced a $0.04/share dividend and provided guidance.
Q1 2015 results included:
Record sales of $18.9mm, +13% vs. Q1 2014 Operating income of $2.3mm vs. an operating loss of $0.2mm Operating margin of 12% Net income of $1.4mm vs. a net loss of $0.2mm Earnings of $0.08 per diluted share vs. ($0.01) EBITDA of $3.2mm vs. $0.6mmQ1 2015 sales of $18.9mm increased 13% (+14% organic) vs. Q1 2014. International sales increased 15%, while The Americas... More
